Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore

SABS stock price forecast

How will SABS stock perform in 2026 and 2030?

This page primarily displays the projected price range for SABS stock over the next 12 months, as well as trading recommendations for the next three months. This data is based on the historical performance of SABS, the development trends of SAB Biotherapeutics, Inc., and a summary of analysis reports from major international investment banks and Wall Street research institutions, along with price analyses and forecasts from well-known analysts on platforms such as TradingView and Reddit. Together, these sources form a comprehensive market outlook for SABS. The forecast includes potential high, median, and low price scenarios to help users understand possible future price movements across different time horizons.

This page combines SAB Biotherapeutics, Inc.'s financial performance and industry trends to provide short-term price predictions for SABS stock over the next one to two years, as well as long-term price predictions extending to 2030.

The data is updated regularly as new market information becomes available. The information on this page is for reference only and does not constitute investment advice.

1-year SABS stock price forecast

Price target:
7.79 USD
+102.34%
Based on 1-year price forecasts from 43 analysts, the highest estimate is 11.23 USD, while the lowest estimate is 3.69 USD.

Analyst rating for SABS

Based on ratings from 38 analysts over the past three months, the overall consensus is Hold.

Strong buy
8
Buy
12
Hold
1
Sell
14
Strong sell
3

FAQ

How has SABS's EPS performed recently?

SABS's EPS is projected to reach -- USD next quarter. Explore more SAB Biotherapeutics, Inc. financial data and stay up to date on the company's latest developments on the SABS stock details page.

What is the revenue forecast for SABS next quarter?

SAB Biotherapeutics, Inc.'s revenue is projected to reach 0.00 USD USD in the next quarter. You can view SAB Biotherapeutics, Inc.'s revenue and earnings on the SABS stock details page.

What is the price target for SABS?

Based on analyst estimates, the most likely target price for SABS over the next 12 months is 7.79 USD, with a projected high of 11.23 USD and a projected low of 3.69 USD. To track whether this target is reached within the next year, you can view the SABS stock price chart on the SABS stock details page to check the current SABS stock price, or follow the latest developments related to SABS on the SABS Stock News page.

What is the analyst rating for SABS?

We collected ratings from 38 analysts who have evaluated SABS stock over the past three months. Most analysts maintain a Hold outlook, and after aggregating all opinions, the overall consensus rating is Hold. Please note that this information does not constitute trading advice. You should still conduct your own research.

What is the projected price of SABS stock in 2030?

Based on price forecasts and analyses of SAB Biotherapeutics, Inc. from Wall Street analysts and major investment banks, SABS is projected to trade between 7.70 USD and 38.50 USD in 2030.

SABS stock chart

SABS stock details

SABS stock price change

On the last trading day, SABS stock closed at 3.85 USD, with a price change of -6.55% for the day.

Trade stock futures

About Bitget

The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more
NASDAQ/
SABS stock price forecast